Advertisement

Cheminformatics analysis of natural products: Lessons from nature inspiring the design of new drugs

  • Peter Ertl
  • Ansgar Schuffenhauer
Part of the Progress in Drug Research book series (PDR, volume 66)

Abstract

Natural products (NPs) have evolved over a very long natural selection process to form optimal interactions with biological macromolecules. NPs are therefore an extremely useful source of inspiration for the design of new drugs. In the present study we report the results of a cheminformatics analysis of more than 130,000 NP structures. The physicochemical properties of NPs and their typical structural features are compared to those of bioactive molecules and average organic molecules. The relationship between the structure of NPs and the type of organism from which they have come has also been analyzed. The aim of this study was to identify those properties and structural features which are typical for NPs and discriminate this class of molecules from common synthetic molecules, with the ultimate goal being to provide a guide for the design of novel NP-like bioactive structures. Hopefully the results of this analysis help to eliminate the old myth about NPs as being ‘too complex’ or having ‘bad properties’, as well as help us to focus on these areas of NP structural space which are essential for biological activity, taking advantage of the process of natural selection over billions of years to guide us to new and as yet unexplored areas of the Chemical Structure Universe.

Keywords

Natural Product Polar Surface Area Sugar Unit Common Scaffold Molecular Polar Surface Area 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981–2002. J Nat Prod 66: 1022–1037PubMedCrossRefGoogle Scholar
  2. 2.
    Rouhi AM (2003) Rediscovering natural products. Chem Eng News 81: 77–91Google Scholar
  3. 3.
    Rouhi AM (2003) Betting on natural products for cures. Chem Eng News 81: 93–103Google Scholar
  4. 4.
    Kubinyi H (2003) Drug research: myths, hype and reality. Nature Rev Drug Disc 2: 665–668CrossRefGoogle Scholar
  5. 5.
    Schreiber SL (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287: 1964–1969PubMedCrossRefGoogle Scholar
  6. 6.
    Tan DS (2005) Diversity-oriented synthesis: exploring the intersections between chemistry and biology. Nature Chem Biol 1: 74–84CrossRefGoogle Scholar
  7. 7.
    Kingston D, Newman D (2002) Mother nature’s combinatorial libraries; their influence on the synthesis of drugs. Curr Opin Drug Disc Dev 5: 304–316Google Scholar
  8. 8.
    Breinbauer R, Manger M, Scheck M, Waldmann H (2002) Natural Product Guided Compound Library Development. Curr Med Chem 9: 2129–2145PubMedGoogle Scholar
  9. 9.
    Firn RD, Jones CG (2003) Natural products — a simple model to explain chemical diversity. Nat Prod Rep 20: 382–391PubMedCrossRefGoogle Scholar
  10. 10.
    Henkel T, Brunne RM, Müller H, Reichel F (1999) Statistical investigation into the structural complementarity of natural products and synthetic compounds. Angew Chem Int Ed 38: 643–647CrossRefGoogle Scholar
  11. 11.
    Stahura FL, Godden JW, Xue L, Bajorath J (2000) Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J Chem Inf Comput Sci 40: 1245–1252PubMedCrossRefGoogle Scholar
  12. 12.
    Lee ML, Schneider G (2001) Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. J Comb Chem 3: 284–289PubMedCrossRefGoogle Scholar
  13. 13.
    Feher M, Schmidt JM (2003) Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry. J Chem Inf Comput Sci 43: 218–227PubMedCrossRefGoogle Scholar
  14. 14.
    Wessjohann LA, Ruijter E, Garcia-Rivera D, Brandt W (2005) What can a chemist learn from nature’s macrocycles? — A brief, conceptual view. Mol Div 9: 171–186CrossRefGoogle Scholar
  15. 15.
    Koch M, Schuffenhauer A, Scheck M, Wetzel S, Casaulta M, Odermatt A, Ertl P, Waldmann H (2005), Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc Natl Acad Sci USA 102: 17272–17277PubMedCrossRefGoogle Scholar
  16. 16.
    Haustedt LO, Mang C, Siems K, Schiewe H (2006) Rational approaches to natural-product-based drug design. Curr Opin Drug Disc Dev 9: 445–462Google Scholar
  17. 17.
    CRC Dictionary of Natural Products, v15.1 (2006) CRC Press. Available at: http://www.crcpress.com/Google Scholar
  18. 18.
    Thorson JS, Vogt T (2005) Glycosylated natural products. In: CH Wong (ed.): Carbohydrate-based drug discovery. Wiley-VCH Verlag, Weinheim, 685–711Google Scholar
  19. 19.
    WDI, Derwent World Drug Index. Available at: http://www.derwent.com/products/lr/wdi/Google Scholar
  20. 20.
    MDDR, MDL Drug Data Report. Available at: http://www.prous.com/product/electron/mddr.htmlGoogle Scholar
  21. 21.
    Pipeline Pilot v 5.0, Scitegic Inc. Available at: http://www.scitegic.comGoogle Scholar
  22. 22.
    Molinspiration Cheminformatics. Available at: http://www.molinspiration.comGoogle Scholar
  23. 23.
    Available at: http://www.biobyte.com/Google Scholar
  24. 24.
    The Integrated Taxonomic Information System (ITIS). Available at: http://www.itis.usda.govGoogle Scholar
  25. 25.
    Ertl P, Rohde B, Selzer P (2000) Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 43: 3714–3717PubMedCrossRefGoogle Scholar
  26. 26.
    Available at: http://en.wikipedia.org/wiki/Principal_components_analysisGoogle Scholar
  27. 27.
    Ertl P (2003) Cheminformatics analysis of organic substituents: Identification of the most common substituents, calculation of substituent properties and automatic identification of drug-like bioisosteric groups. J Chem Inf Comput Sci 43: 374–380PubMedCrossRefGoogle Scholar
  28. 28.
    Haefner B (2003) Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today 8: 536–544PubMedCrossRefGoogle Scholar
  29. 29.
    Drews J (2003) In quest of tomorrow’s medicines. Springer, New YorkGoogle Scholar

Copyright information

© Birkhäuser Verlag, Basel (Switzerland) 2008

Authors and Affiliations

  • Peter Ertl
    • 1
  • Ansgar Schuffenhauer
    • 1
  1. 1.Novartis Institutes for BioMedical ResearchBaselSwitzerland

Personalised recommendations